Compare Sibanye Stillwater Ltd (SBSW) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sibanye Stillwater Ltd vs TransMedics Group Inc — how do they compare? Sibanye Stillwater Ltd trades at $8.59 (market cap $5.66B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Sibanye Stillwater Ltd is far larger — about 2.2× TransMedics Group Inc's market cap, and Sibanye Stillwater Ltd pays a 3.89% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| SBSW | TMDX | |
|---|---|---|
Market Cap | $5.66B | $2.54B |
Sector | Basic Materials | Technology |
52-Week High | $21.12 | $150.42 |
52-Week Low | $7.27 | $61.99 |
Enterprise Value | $7.28B | $2.94B |
Dividend Yield | 3.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
